IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+8.3%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$130M
AUM Growth
–
Cap. Flow
+$130M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
49.66%
Holding
62
New
52
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Amgen
AMGN
|
$11.4M |
| 2 |
Merck
MRK
|
$8.76M |
| 3 |
Biogen
BIIB
|
$8.39M |
| 4 |
Zimmer Biomet
ZBH
|
$7.46M |
| 5 |
Gilead Sciences
GILD
|
$6.38M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 83.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amgen
AMGN
$155B
| $11.4M | 6.5% |
+100,000
| New | +$11.4M |
|
|
2
Merck
MRK
$210B
| $8.76M | 4.99% |
+175,000
| New | +$8.76M |
|
|
3
Biogen
BIIB
$19.4B
| $8.39M | 4.78% |
+30,000
| New | +$8.39M |
|
|
4
Zimmer Biomet
ZBH
$21B
| $7.46M | 4.25% |
+80,000
| New | +$7.46M |
|
|
5
Gilead Sciences
GILD
$140B
| $6.38M | 3.64% |
+85,000
| New | +$6.38M |
|
6
Viatris
VTRS
$12.3B
| $4.99M | 2.84% |
+115,000
| New | +$4.99M |
|
7
Celldex Therapeutics
CLDX
$1.47B
| $4.84M | 2.76% |
+200,000
| New | +$4.84M |
|
8
Cigna
CI
$80.3B
| $4.37M | 2.49% |
+50,000
| New | +$4.37M |
|
9
Ligand Pharmaceuticals
LGND
$3.15B
| $3.95M | 2.25% |
+75,000
| New | +$3.95M |
|
10
Incyte
INCY
$16.5B
| $3.8M | 2.16% |
+75,000
| New | +$3.8M |
|
|
TRNX
11
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $3.76M | 2.14% |
+200,000
| New | +$3.76M |
|
|
COV
12
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $3.41M | 1.94% |
+50,000
| New | +$3.41M |
|
13
Alkermes
ALKS
$4.78B
| $3.05M | 1.74% |
+75,000
| New | +$3.05M |
|
|
ARTC
14
DELISTED
ARTHROCARE CORP
ARTC
| $3.02M | 1.72% |
+75,000
| New | +$3.02M |
|
|
ELGX
15
DELISTED
Endologix Inc
ELGX
| $2.79M | 1.59% |
+160,000
| New | +$2.79M |
|
16
Lisata Therapeutics
LSTA
$19.9M
| $2.73M | 1.55% |
+400,000
| New | +$2.73M |
|
17
Puma Biotechnology
PBYI
$254M
| $2.59M | 1.48% |
+25,000
| New | +$2.59M |
|
|
ETRM
18
DELISTED
EnteroMedics Inc.
ETRM
| $2.3M | 1.31% |
+1,125,000
| New | +$2.3M |
|
|
ITMN
19
DELISTED
INTERMUNE INC
ITMN
| $2.21M | 1.26% |
+150,000
| New | +$2.21M |
|
|
WMGI
20
DELISTED
Wright Medical Group Inc
WMGI
| $2.15M | 1.23% |
+70,000
| New | +$2.15M |
|
21
DexCom
DXCM
$29.5B
| $2.13M | 1.21% |
+60,000
| New | +$2.13M |
|
22
Esperion Therapeutics
ESPR
$448M
| $2.06M | 1.17% |
+150,000
| New | +$2.06M |
|
|
AERI
23
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.02M | 1.15% |
+112,500
| New | +$2.02M |
|
24
Nuwellis
NUWE
$4.6M
| $1.8M | 1.02% |
+185,000
| New | +$1.8M |
|
|
ESRX
25
DELISTED
Express Scripts Holding Company
ESRX
| $1.76M | 1% |
+25,000
| New | +$1.76M |
|